한글목차

구인두암 진단 및 치료제 동향 및 예측

세계의 구인두암 진단 및 치료 시장은 2024년부터 2030년까지 복합 연간 성장률(CAGR) 9.2%를 나타낼 전망이며, 2030년까지 33억 달러에 달할 것으로 예측됩니다. 이 시장의 주요 촉진요인은 중 인두암의 이환율 증가, 담배와 알코올의 대량 소비, 인유두종 바이러스(hpv) 감염 증가입니다. 세계의 구인두암 진단 및 치료제 시장의 미래는 병원과 외래수술센터(ASC) 시장에서의 비즈니스 기회에 의해 유망시되고 있습니다.

구인두암 진단 및 치료제 시장 인사이트

Lucintel은 CT 스캔이 예측 기간 동안 가장 높은 성장을 이룰 것으로 예측됩니다.

병원은 구인두암의 진단 및 치료의 주요 시설로서 기능하며 이러한 중요한 서비스를 제공하는 데 필수적인 인프라와 전문적인 전문 지식을 가지고 있기 때문에 가장 큰 부문입니다. 계속할 것입니다.

아시아태평양은 구인두암 환자 증가와 구강인두에 대한 의식이 높아짐에 따라 예측기간 동안 가장 높은 성장을 이룰 것으로 예상됩니다.

이 보고서는 다음 11가지 주요 질문에 답변합니다.

• Q.1. 시장 부문 중 가장 유망하고 고성장하는 기회는 무엇인가?
• Q.2.향후 성장이 가속되는 부문과 그 이유는?
• Q.3. 앞으로 성장이 가속될 것으로 보이는 지역과 그 이유는?
• Q.4. 시장 역학에 영향을 미치는 주요 요인은? 시장의 주요 과제와 비즈니스 리스크는?
• Q.5. 이 시장에서의 비즈니스 리스크와 경쟁 위협은?
• Q.6. 이 시장에서의 새로운 동향과 그 이유는?
• Q.7. 시장에서 고객 수요 변화에는 어떤 것이 있는가?
• Q.8. 이 시장에서의 새로운 개발과 그 개발을 리드하고 있는 기업은?
• Q.9.이 시장의 주요 기업은? 주요 기업은 사업 성장을 위해 어떤 전략적 노력을 추진하고 있는가?
• Q.10. 이 시장에서 경쟁 제품은 어떠한 것이며, 재료 및 제품의 대체로 인한 시장 점유율 저하의 위협은 어느 정도입니까?
• Q.11. 지난 5년 동안 어떤 M&D가 수행되었고 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 구인두암 진단 및 치료 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 구인두암의 진단 및 치료 시장 동향(2018-2023년) 및 예측(2024-2030년)
• 유형별 세계의 구인두암의 진단 및 치료 시장
  • 내시경 검사
  • 생검
  • 이미지화
  • MRI 스캔
  • CT 스캔
  • 반려동물 CT 스캔
• 치료별 세계의 구인두암의 진단 및 치료 시장
  • 수술
  • 화학요법
  • 방사선치료
  • 표적요법
  • 기타
• 최종 용도별 세계의 구인두암의 진단 및 치료 시장
  • 병원
  • 외래수술센터(ASC)
  • 기타

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 세계의 구인두암의 진단 및 치료 시장
• 북미의 구인두암 진단 및 치료 시장
• 유럽의 구인두암 진단 및 치료 시장
• 아시아태평양 중 인두암 진단 및 치료 시장
• 기타 지역 중 인두암 진단 및 치료 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상의 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 유형별 세계의 구인두암의 진단 및 치료 시장의 성장 기회
  • 치료별 세계의 구인두암 진단 및 치료 시장의 성장 기회
  • 최종 용도별 세계의 구인두암 진단 및 치료 시장의 성장 기회
  • 지역별 세계의 구인두암 진단 및 치료 시장의 성장 기회
• 세계의 구인두암의 진단 및 치료 시장에서의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 구인두암 진단 및 치료 시장의 능력 확대
  • 세계의 구인두암의 진단 및 치료 시장에서의 합병, 인수, 합작 사업
  • 인증 및 라이센스

제7장 유력 기업의 기업 프로파일

• Ab Sciences
• Advaxis
• AstraZeneca
• Bayer
• Boston Biomedical
• Bristol-Myers Squibb
• GE Healthcare
• Immunovaccine
• Inovio Pharmaceuticals
• Merck

영문목차

Oropharyngeal Cancer Diagnosis and Therapeutics Trends and Forecast

The future of the global oropharyngeal cancer diagnosis and therapeutics market looks promising with opportunities in the hospital and ambulatory surgery center markets. The global oropharyngeal cancer diagnosis and therapeutics market is expected to reach an estimated $3.3 billion by 2030 with a CAGR of 9.2% from 2024 to 2030. The major drivers for this market are rising incidence of oropharyngeal cancer, high tobacco and alcohol consumption ,and rise in human papillomavirus (hpv) infections.

A more than 150-page report is developed to help in your business decisions.

Oropharyngeal Cancer Diagnosis and Therapeutics by Segment

The study includes a forecast for the global oropharyngeal cancer diagnosis and therapeutics by type, treatment, end use, and region.

Oropharyngeal Cancer Diagnosis and Therapeutics Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Endoscopy
• Biopsy
• Imaging
• MRI Scan
• CT Scan
• Pet-CT Scan

Oropharyngeal Cancer Diagnosis and Therapeutics Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

• Surgery
• Chemotherapy
• Radiation Therapy
• Targeted Therapy
• Others

Oropharyngeal Cancer Diagnosis and Therapeutics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Ambulatory Surgery Centers
• Others

Oropharyngeal Cancer Diagnosis and Therapeutics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Oropharyngeal Cancer Diagnosis and Therapeutics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies oropharyngeal cancer diagnosis and therapeutics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the oropharyngeal cancer diagnosis and therapeutics companies profiled in this report include-

• Ab Sciences
• Advaxis
• Astrazeneca
• Bayer
• Boston Biomedical
• Bristol-Myers Squibb
• Ge Healthcare
• Immunovaccine
• Inovio Pharmaceuticals
• Merck

Oropharyngeal Cancer Diagnosis and Therapeutics Market Insights

Lucintel forecasts that CT scan is expected to witness highest growth over the forecast period.

Hospitals will remain the largest segment as it serves as the primary facilities for diagnosing and treating oropharyngeal cancer and possess the essential infrastructure and specialized expertise required to deliver these crucial services.

APAC is expected to witness highest growth over the forecast period due to rising cases of oropharyngeal cancer and increasing awareness towards oropharyngeal.

Features of the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market

Market Size Estimates: Oropharyngeal cancer diagnosis and therapeutics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Oropharyngeal cancer diagnosis and therapeutics market size by type, treatment, end use, and region. in terms of value ($B).

Regional Analysis: Oropharyngeal cancer diagnosis and therapeutics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, treatments , end uses, and region.s for the oropharyngeal cancer diagnosis and therapeutics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the oropharyngeal cancer diagnosis and therapeutics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the oropharyngeal cancer diagnosis and therapeutics market size?

Answer: The global oropharyngeal cancer diagnosis and therapeutics market is expected to reach an estimated $3.3 billion by 2030.

Q.2. What is the growth forecast for oropharyngeal cancer diagnosis and therapeutics market?

Answer: The global oropharyngeal cancer diagnosis and therapeutics market is expected to grow with a CAGR of 9.2% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the oropharyngeal cancer diagnosis and therapeutics market?

Answer: The major drivers for this market are rising incidence of oropharyngeal cancer, high tobacco and alcohol consumption, and rise in human papillomavirus (HPV) infections.

Q.4. What are the major segments for oropharyngeal cancer diagnosis and therapeutics market?

Answer: The future of the oropharyngeal cancer diagnosis and therapeutics market looks promising with opportunities in the hospital and ambulatory surgery center markets.

Q.5. Who are the key oropharyngeal cancer diagnosis and therapeutics market companies?

Answer: Some of the key oropharyngeal cancer diagnosis and therapeutics companies are as follows:

• Ab Sciences
• Advaxis
• AstraZeneca
• Bayer
• Boston Biomedical
• Bristol-Myers Squibb
• GE Healthcare
• Immunovaccine
• Inovio Pharmaceuticals
• Merck

Q.6. Which oropharyngeal cancer diagnosis and therapeutics market segment will be the largest in future?

Answer: Lucintel forecasts that CT scan is expected to witness highest growth over the forecast period.

Q.7. In oropharyngeal cancer diagnosis and therapeutics market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to rising cases of oropharyngeal cancer and increasing awareness towards oropharyngeal.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the oropharyngeal cancer diagnosis and therapeutics market by type (endoscopy, biopsy, imaging, MRI scan, CT scan, and pet-CT scan), treatment (surgery, chemotherapy, radiation therapy, targeted therapy, and others), end use (hospitals, ambulatory surgery centers, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by Type
  • 3.3.1: Endoscopy
  • 3.3.2: Biopsy
  • 3.3.3: Imaging
  • 3.3.4: MRI Scan
  • 3.3.5: CT Scan
  • 3.3.6: Pet-CT Scan
• 3.4: Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by Treatment
  • 3.4.1: Surgery
  • 3.4.2: Chemotherapy
  • 3.4.3: Radiation Therapy
  • 3.4.4: Targeted Therapy
  • 3.4.5: Others
• 3.5: Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Ambulatory Surgery Centers
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by Region
• 4.2: North American Oropharyngeal Cancer Diagnosis and Therapeutics Market
  • 4.2.2: North American Oropharyngeal Cancer Diagnosis and Therapeutics Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others
• 4.3: European Oropharyngeal Cancer Diagnosis and Therapeutics Market
  • 4.3.1: European Oropharyngeal Cancer Diagnosis and Therapeutics Market by Type: Endoscopy, Biopsy, Imaging, MRI Scan, CT Scan, and Pet-CT Scan
  • 4.3.2: European Oropharyngeal Cancer Diagnosis and Therapeutics Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others
• 4.4: APAC Oropharyngeal Cancer Diagnosis and Therapeutics Market
  • 4.4.1: APAC Oropharyngeal Cancer Diagnosis and Therapeutics Market by Type: Endoscopy, Biopsy, Imaging, MRI Scan, CT Scan, and Pet-CT Scan
  • 4.4.2: APAC Oropharyngeal Cancer Diagnosis and Therapeutics Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others
• 4.5: ROW Oropharyngeal Cancer Diagnosis and Therapeutics Market
  • 4.5.1: ROW Oropharyngeal Cancer Diagnosis and Therapeutics Market by Type: Endoscopy, Biopsy, Imaging, MRI Scan, CT Scan, and Pet-CT Scan
  • 4.5.2: ROW Oropharyngeal Cancer Diagnosis and Therapeutics Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by Type
  • 6.1.2: Growth Opportunities for the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by Treatment
  • 6.1.3: Growth Opportunities for the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by End Use
  • 6.1.4: Growth Opportunities for the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by Region
• 6.2: Emerging Trends in the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Ab Sciences
• 7.2: Advaxis
• 7.3: AstraZeneca
• 7.4: Bayer
• 7.5: Boston Biomedical
• 7.6: Bristol-Myers Squibb
• 7.7: GE Healthcare
• 7.8: Immunovaccine
• 7.9: Inovio Pharmaceuticals
• 7.10: Merck